The TNF Paradox in Cancer Progression and Immunotherapy.

Montfort, Anne; Colacios, Céline; Levade, Thierry; Andrieu-Abadie, Nathalie; Meyer, Nicolas; Ségui, Bruno

Montfort, Anne; Colacios, Céline; Levade, Thierry; Andrieu-Abadie, Nathalie; Meyer, Nicolas; Ségui, Bruno.

Afiliação

Montfort A; INSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
Colacios C; INSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
Levade T; Université Toulouse III - Paul Sabatier, Toulouse, France.
Andrieu-Abadie N; INSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
Meyer N; Université Toulouse III - Paul Sabatier, Toulouse, France.
Ségui B; Laboratoire de Biochimie, Institut Fédératif de Biologie, CHU Purpan, Toulouse, France.

Front Immunol ; 10: 1818, 2019.

Article em En | MEDLINE | ID: mdl-31417576

Assuntos

Imunoterapia; Melanoma; Fator de Necrose Tumoral alfa/imunologia; Animais; Humanos; Melanoma/imunologia; Melanoma/patologia; Melanoma/terapia; Metástase Neoplásica

Palavras-chave

CTLA-4; PD-1; immune escape; melanoma; tumor necrosis factor (TNF)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Imunoterapia / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google